ハイスループットスクリーニング (HTS) の世界市場 (～2023年)：セルベースアッセイ・ラボオンチップ・バイオインフォマティクス
High Throughput Screening Market by Technology (Cell-Based Assays, Lab on a Chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent, Instruments, Software, Service), End User - Global Forecast to 2023
|出版日||ページ情報||英文 245 Pages
|ハイスループットスクリーニング (HTS) の世界市場 (～2023年)：セルベースアッセイ・ラボオンチップ・バイオインフォマティクス High Throughput Screening Market by Technology (Cell-Based Assays, Lab on a Chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent, Instruments, Software, Service), End User - Global Forecast to 2023|
|出版日: 2018年04月24日||ページ情報: 英文 245 Pages||
世界のハイスループットスクリーニング (HTS) の市場は予測期間中7.8%のCAGR (年間複合成長率) で推移し、2018年の148億7000万米ドルから、2023年には216億9000万米ドルの規模に成長すると予測されています。医薬品・バイオテクノロジー企業による各種イニチアチブ、R&D投資の拡大、技術革新、政府による資金投入、ベンチャー投資などの要因が同市場の成長を推進しています。
当レポートでは、世界のハイスループットスクリーニング (HTS) の市場を調査し、市場および技術の定義と概要、市場成長への各種影響因子および市場機会の分析、産業および技術動向、製品&サービス・技術・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。
The HTS market is expected to reach USD 21.69 billion by 2023 from an estimated USD 14.87 billion in 2018, at a CAGR of 7.8%. The initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological developments in HTS, and the availability of government funding and venture capital investments are the factors driving the growth of the HTS market. However, the capital-intensive nature of HTS and complexities in the field of assay development are expected to limit the growth of this market during the forecast period.
On the basis of product & service, the HTS market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. The software segment is expected to register the highest CAGR during the forecast period. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward HTS techniques are some of the factors contributing to the growth of this segment.
On the basis of end user, the HTS market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CROs), and other end users (hospitals and food, agriculture & environmental industries). The contract research organizations segment is expected to register the highest CAGR during the forecast period owing to the increasing outsourcing of HTS services by many pharmaceutical & biotechnology companies.
North America held the largest share of the global HTS market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing R&D spending, growing trend of outsourcing drug discovery services, growing public-private partnerships, and increasing government funding in this region.
Break of primary participants was as mentioned below:
The prominent players in the global HTS market are: Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).
The report analyzes the various HTS products and their adoption pattern. It aims at estimating the market size and future growth potential of the global HTS market for different segments such as product & service, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.